1-4 of 4
Zhuoxiao Cao
Close
Sort by
Journal Articles

Phase I Clinical Study of Humanized BCMA-Single-Domain Antibodies-Targeting CAR T (BCMA-CART) in Patients with Relapsed/Refractory Multiple Myeloma

Gaofeng Zheng, Heng Mei, Gang Ye, Ling Zhou, Cheng Wen, Zhuoxiao Cao, Zhen Cai
Journal: Blood
Blood (2023) 142 (Supplement 1): 3489.
https://doi.org/10.1182/blood-2023-186619
Published: 2023
Journal Articles

Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

Zhuoxiao Cao, Cuiqing Yang, Yifang Wang, Chao Wang, Qingyang Wang, Gang Ye, Tingting Liu, Qin Wang, Huanyu Wang, Yanxue Gong, Biye Wang, Fuwei Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7378.
https://doi.org/10.1182/blood-2022-159289
Published: 2022
Journal Articles

Role of Krüppel-like factors in leukocyte development, function, and disease

Zhuoxiao Cao, Xinghui Sun, Basak Icli, Akm Khyrul Wara, Mark W. Feinberg
Journal: Blood
Blood (2010) 116 (22): 4404–4414.
https://doi.org/10.1182/blood-2010-05-285353
Published: 2010
Journal Articles

Kruppel-Like Factor 10 (KLF10)-Deficient Mice Have Marked Defects In EPC Differentiation, Function, and Angiogenesis

Akm Khyrul Wara, PhD, Kevin Croce, PhD, ShiYin Foo, PhD, Xinghui Sun, PhD, Basak Icli, PhD, Yevgenia Tesmenitsky, PhD, Zhuoxiao Cao, PhD, Fehim Esen, PhD, Malayannan Subramaniam, PhD, Jeffery Kutok, Scott J. Rodig, Thomas Spelsberg, PhD, Anthony Rosenzweig, PhD, Mark Feinberg, PhD
Journal: Blood
Blood (2010) 116 (21): 4314.
https://doi.org/10.1182/blood.V116.21.4314.4314
Published: 2010